Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Efficacy and Safety of BAY 3018250 in Patients With Symptomatic Proximal Deep Vein Thrombosis

NCT06149520 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT06149520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06149520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Efficacy and Safety of BAY 3018250 in Patients With Symptomatic Proximal Deep Vein Thrombosis
Lead sponsor
Bayer
Phase
Phase 2
Overall status
Completed
Start date
January 15, 2024
Completion date
December 2, 2025
Enrollment
283 (actual)
Sites
68

Conditions

As the registry lists them; a condition with its own page is linked.

symptomatic proximal deep vein thrombosis, thrombolysis